Long-term medication use linked to persistent gut microbiome alterations
A study of 2,500 individuals reveals that common medications, including antidepressants and beta-blockers, cause persistent changes to the gut microbiome…

Research indicates that common pharmaceutical treatments can induce lasting changes in the human gut microbiome that persist for years after the cessation of therapy. A study of over 2,500 individuals demonstrates that these microbial shifts are not exclusive to antibiotics but extend to several widely prescribed drug classes, including antidepressants, beta-blockers, proton pump inhibitors, and benzodiazepines.
The findings suggest that historical prescription data is a critical variable in understanding individual microbiome composition. Specifically, benzodiazepines were found to exert effects on microbial communities comparable in magnitude to those of broad-spectrum antibiotics, challenging the assumption that microbiome disruption is primarily a consequence of current medication use.
Data analysis revealed that medications within the same therapeutic class do not necessarily produce uniform effects on gut bacteria. This suggests that clinical and research assessments must evaluate individual drugs rather than relying on broad class-based categorizations. The persistence of these microbial "fingerprints" implies that past medical interventions may confound current diagnostic interpretations of the microbiome.
These results carry implications for medical research and clinical practice, as they indicate that biological traces of prior treatments remain detectable long-term. Future studies aiming to link microbiome patterns to specific diseases or health outcomes will likely need to incorporate comprehensive medication histories to accurately isolate the impact of past pharmaceutical exposure from other environmental or physiological factors.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- GSK wins FDA approval for Nelkarmi after 49% response rate
- Europe faces 35,000 drug-resistance deaths a year
- Srivastava warns 1 in 5 men over 50 risk osteoporosis fractures
- Rare FN1 mutation may limit brain-vessel damage in APOE ε4 carriers
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

